RxDoctor Payments Data

Stacy Friesner

Acute Care · Columbus, OHNPI 1649250119

Payments from drug & device makers

$893in general payments, 2019–2025

Across 53 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$202
  • GSK$140
  • Takeda Pharmaceuticals U.S.A., Inc.$89
  • Mylan Specialty L.p.$65
  • Actelion Pharmaceuticals US, Inc.$63
  • Boehringer Ingelheim$59
  • plus $276 from 11 others

What the payments were for

  • Food & beverage$891100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$893 in reported general payments places this provider in the 75th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$179,974
Medicare patients
124
Services billed
2,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Glatiramer Acetate24$60,500
EliquisApixaban136$40,296
JardianceEmpagliflozin75$19,950
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$7,118
JanuviaSitagliptin Phosphate23$6,666
LinzessLinaclotide11$6,465
Budesonide25$5,915
Tiotropium Bromide11$5,513
XareltoRivaroxaban11$4,737
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$2,329
Carvedilol79$1,949
Potassium Chloride64$1,849
Tramadol Hcl53$1,776
NitrofurantoinNitrofurantoin Macrocrystal39$1,760
Pantoprazole Sodium42$1,627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$59$19,95075 claims
GSKTrelegy Ellipta$140$7,11817 claims
Johnson & JohnsonXarelto$37$4,73711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,101 acute care providers in Ohio.

Other acute care in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →